Home | Anti-PD1 2C12 in patients with relapsed or refractory Hodgkin lymphoma

The revisions let you track differences between multiple versions of a post.

To edit, publish or delete one of the revisions below, click on its saved date.

Published clinical_trials Anti-PD1 2C12 in patients with relapsed or refractory Hodgkin lymphoma has only one revision
RevisionStatus
Saved 18/05/2026 - 10:47am by Gladyscurrent revision (published)